Surgical site infections (SSIs) affect tens of thousands of patients in Europe annually, posing a massive drain on hospital budgeting. This year’s president of the Surgical Infection Society of Europe, Prof Dr REINHOLD FÜGGER, discusses causes, impact, and the use of InteguSeal, a new microbial sealant that could significantly reduce occurrence.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
